Michela Giustozzi
Overview
Explore the profile of Michela Giustozzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talerico R, Brando E, Luzi L, Vedovati M, Giustozzi M, Verso M, et al.
Intern Emerg Med
. 2024 Jun;
19(6):1645-1652.
PMID: 38943034
It is still uncertain whether direct oral anticoagulants (DOACs) perform better than vitamin K antagonists (VKAs) in subjects with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD). The...
2.
Giustozzi M, Calvello C, Eusebi P, Paoletti F, Silvestrelli G, Mazzetti M, et al.
Epilepsia
. 2024 Jun;
65(8):e141-e147.
PMID: 38888914
Research on cerebrovascular events in atrial fibrillation (AF) patients taking non-vitamin K antagonist oral anticoagulants (NOACs) with antiseizure medications (ASMs) is limited, highlighting a significant gap in literature. We assessed...
3.
Dentali F, Campanini M, Bonaventura A, Fontanella L, Zuretti F, Tavecchia L, et al.
TH Open
. 2024 Jan;
8(1):e55-e60.
PMID: 38222040
Venous thromboembolism (VTE) in hospitalized medically ill patients is a significant cause of morbidity and mortality. Guidelines suggest that VTE and bleeding risk assessment models (RAMs) should be integrated into...
4.
Becattini C, Giustozzi M, Portillo J, Fernandez-Capitan C, Lobo J, Peris M, et al.
Res Pract Thromb Haemost
. 2023 Oct;
7(6):102172.
PMID: 37810416
Background: Patients with brain cancer have been excluded or were underrepresented in studies on the treatment of venous thromboembolism (VTE), mainly due to the fear of intracranial hemorrhage (ICH). Objectives:...
5.
Vedovati M, Giustozzi M, Munoz A, Bertoletti L, Cohen A, Klok F, et al.
Eur J Intern Med
. 2023 Feb;
112:29-36.
PMID: 36774305
Risks of recurrence and treatment-emergent bleeding are high in patients with cancer-associated venous thromboembolism (VTE) but factors associated with these risks remain substantially undefined. The aim of this analysis in...
6.
Siniarski A, Gasecka A, Borovac J, Papakonstantinou P, Bongiovanni D, Ehrlinder H, et al.
J Card Fail
. 2023 Jan;
29(4):517-526.
PMID: 36632933
Heart failure (HF) is a clinical syndrome that is divided into 3 subtypes based on the left ventricular ejection fraction. Every subtype has specific clinical characteristics and concomitant diseases, substantially...
7.
Giustozzi M, Becattini C, Roila F, Agnelli G, Mandala M
Blood Adv
. 2022 Dec;
7(2):283-284.
PMID: 36453644
No abstract available.
8.
Mosconi M, Maraziti G, Paciaroni M, Giustozzi M, Vedovati M, Bogliari G, et al.
Eur Neurol
. 2022 Sep;
86(1):13-24.
PMID: 36099877
Background: The efficacy and safety profiles of nonrecommended direct oral anticoagulant (DOAC) doses in patients with nonvalvular atrial fibrillation (NVAF) are still undefined. Summary: We searched for randomized controlled trials...
9.
Giustozzi M, Proietti G, Becattini C, Roila F, Agnelli G, Mandala M
Blood Adv
. 2022 Jun;
6(16):4873-4883.
PMID: 35772127
Anticoagulant treatment in patients with primary and metastatic brain cancer is a concern due to risk of intracranial hemorrhage (ICH). We performed a systematic review and meta-analysis to evaluate the...
10.
Paciaroni M, Caso V, Agnelli G, Mosconi M, Giustozzi M, Seiffge D, et al.
Stroke
. 2022 May;
53(8):2620-2627.
PMID: 35543133
Background: In patients with atrial fibrillation who suffered an ischemic stroke while on treatment with nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent ischemic events and major bleedings...